Core Capex To Operating Cash Flow from 2010 to 2024

CORZZ Stock   14.10  0.29  2.02%   
Core Scientific, Capex To Operating Cash Flow yearly trend continues to be fairly stable with very little volatility. Capex To Operating Cash Flow is likely to outpace its year average in 2024. During the period from 2010 to 2024, Core Scientific, Capex To Operating Cash Flow regression line of annual values had r-squared of  0.67 and arithmetic mean of (29.89). View All Fundamentals
 
Capex To Operating Cash Flow  
First Reported
2010-12-31
Previous Quarter
0.24819547
Current Value
0.26
Quarterly Volatility
22.0722826
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Core Scientific, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Core Scientific,'s main balance sheet or income statement drivers, such as Tax Provision of 645.4 K, Depreciation And Amortization of 116.5 M or Interest Expense of 63.8 M, as well as many indicators such as Price To Sales Ratio of 3.06, Dividend Yield of 0.0 or Days Sales Outstanding of 5.46. Core financial statements analysis is a perfect complement when working with Core Scientific, Valuation or Volatility modules.
  
Check out the analysis of Core Scientific, Correlation against competitors.

Latest Core Scientific,'s Capex To Operating Cash Flow Growth Pattern

Below is the plot of the Capex To Operating Cash Flow of Core Scientific, Tranche over the last few years. It is Core Scientific,'s Capex To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Core Scientific,'s overall financial position and show how it may be relating to other accounts over time.
Capex To Operating Cash Flow10 Years Trend
Slightly volatile
   Capex To Operating Cash Flow   
       Timeline  

Core Capex To Operating Cash Flow Regression Statistics

Arithmetic Mean(29.89)
Geometric Mean9.19
Coefficient Of Variation(73.84)
Mean Deviation20.10
Median(44.97)
Standard Deviation22.07
Sample Variance487.19
Range46.8377
R-Value0.82
Mean Square Error172.34
R-Squared0.67
Significance0.0002
Slope4.04
Total Sum of Squares6,821

Core Capex To Operating Cash Flow History

2024 0.26
2023 0.25
2022 1.87
2021 -1.04
2020 -0.066

About Core Scientific, Financial Statements

Core Scientific, investors use historical fundamental indicators, such as Core Scientific,'s Capex To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Core Scientific,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capex To Operating Cash Flow 0.25  0.26 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Core Stock Analysis

When running Core Scientific,'s price analysis, check to measure Core Scientific,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific, is operating at the current time. Most of Core Scientific,'s value examination focuses on studying past and present price action to predict the probability of Core Scientific,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific,'s price. Additionally, you may evaluate how the addition of Core Scientific, to your portfolios can decrease your overall portfolio volatility.